Search
Ekso Bionics Ord Shs
CHRNAdd to Watchlist
22.510USD
+0.380+1.72%
Close 06/25, 16:00（ET）Quotes delayed by 15 min
80.20MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
2
analysts
Buy
Current Rating
9.500
Target Price
-63.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
4
Median
6
Average
Company name
Ratings
Analysts
Ekso Bionics Ord Shs
CHRN
2
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Ekso Bionics Ord Shs's expected revenue for the next quarter?
Ekso Bionics Ord Shs's expected revenue is 4.55M.
How have Ekso Bionics Ord ShsCHRN's recent earnings per share performed?
The market expectation was USD -2.04, while Ekso Bionics Ord ShsCHRN's earnings per share (EPS) for the previous quarter was USD -4.91. EPS for the next quarter is expected at USD -0.23.
What is the analyst rating for Ekso Bionics Ord Shs?
Based on the ratings of Ekso Bionics Ord Shs's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
